2D Nanosheets-A New Class of Therapeutic Formulations against Cancer

• Published in: Pharmaceutics Vol. 13; no. 11; p. 1803
• Main Authors: Manisekaran, Ravichandran, García-Contreras, René, Rasu Chettiar, Aruna-Devi, Serrano-Díaz, Paloma, Lopez-Ayuso, Christian Andrea, Arenas-Arrocena, Ma Concepción, Hernández-Padrón, Genoveva, López-Marín, Luz M, Acosta-Torres, Laura Susana
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 28.10.2021; MDPI
• Subjects: 2D material; Biocompatibility; black phosphorus; Cancer therapies; Carbon; Chemotherapy; Clinical trials; Drug delivery systems; Drugs; Graphene; Hydrogels; LDHs; Medical research; Morphology; MXene; Nanomaterials; nanosheets; R&D; Research & development; Review; transition metal dichalcogenides; LDHs; therapeutics; transition metal dichalcogenides; MXene; 2D material; black phosphorus; drug delivery; nanosheets
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics13111803

Researchers in cancer nanomedicine are exploring a revolutionary multifaceted carrier for treatment and diagnosis, resulting in the proposal of various drug cargos or "magic bullets" in this past decade. Even though different nano-based complexes are registered for clinical trials, very few products enter the final stages each year because of various issues. This prevents the formulations from entering the market and being accessible to patients. In the search for novel materials, the exploitation of 2D nanosheets, including but not limited to the highly acclaimed graphene, has created extensive interest for biomedical applications. A unique set of properties often characterize 2D materials, including semiconductivity, high surface area, and their chemical nature, which allow simple decoration and functionalization procedures, structures with high stability and targeting properties, vectors for controlled and sustained release of drugs, and materials for thermal-based therapies. This review discusses the challenges and opportunities of recently discovered 2D nanosheets for cancer therapeutics, with special attention paid to the most promising design technologies and their potential for clinical translation in the future.